Skip to content
EN
EN FR NL
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Menu
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Menu
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Donate
BIG Members
EN
EN FR NL

Press Release

The odyssey towards metastatic breast cancer survival: The AURORA academic research programme

International Clinical Trials Day 2023

First results from POSITIVE study: Young women with breast can safely have a baby

AURORA, the first international molecular screening programme for metastatic breast cancer, presented at IMPAKT Breast Cancer Conference

New Treatment Option for Young Women with Hormone-Sensitive Breast Cancer

ALTTO Test of Dual HER2 Blockade Finds Single Agent – Trastuzumab – Remains the Gold Standard

Opening of international PANACEA study of patients with HER2+ breast cancer

Belgian Dr. Martine Piccart has received prestigious international Brinker Award for Scientific Distinction in Clinical Research

Pfizer Awards Breast International Group (BIG) $1 Million Research Grant to Support Non‐Drug Related Breast Cancer Research

New England Journal of Medicine” publishes results of MINDACT clinical trial The 70-gene test (Mammaprint®) can significantly reduce use of chemotherapy among breast cancer patients and has the potential to change clinical practice: 46% of early stage breast cancer patients classified as high-risk by traditional methods can avoid chemotherapy

Page1 Page2 Page3 Page4
BIG-supported-by-BIG-against-bc-logo

Breast International Group (BIG) – aisbl

Facebook-f Twitter Instagram Linkedin Youtube Flickr

Head Office

  • Rue de Bretagne 20, 1200 Brussels, Belgium
  • +32 2 486 16 00
  • VAT BE 0468 176 240
  • IBAN BE08 0689 0916 0213

Tax Deduction

Donations greater than or equal to € 40 / year receive a 45% tax reduction. This means your donation of €40 only costs you € 22.

Site Links

  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
      • Become a member
    • Patient advocates
    • Collaborations
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
AERFLABELPMSDEFVblanc

The Breast International Group is proud to adhereto the Code of Ethics of the VEF-AERF

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

Ⓒ 2023- All Rights Are Reserved